Long QT Syndrome
-
Long QT syndrome represents a heterogeneous family of cardiac electrophysiological disorders characterised by QT prolongation and T-wave abnormalities.
Load moreLong QT syndrome represents a heterogeneous family of cardiac electrophysiological disorders characterised by QT prolongation and T-wave abnormalities.
Risk assessment should consider age, gender, prior syncopal history, QT-interval duration, and genetic factors. Beta-blockers are the mainstay of therapy for long QT syndrome, but left cardiac sympathetic denervation and ICD implantation should be considered in patients who remain symptomatic despite beta-blocker therapy. Studies are evaluating genotype-specific therapies that may reduce the risk for life-threatening cardiac events in high-risk patients.
Load Less
-
Pier D Lambiase, Joseph De Bono, Martin Lowe, et alArrhythmia & Electrophysiology Review 2019;8(3):161–5.DOI: https://doi.org/10.15420/aer.2019.8.3.G1
-
Nabil El-Sherif, Gioia Turitto, Mohamed Boutjdir, et alArrhythmia & Electrophysiology Review 2019;8(2):122–30.DOI: https://doi.org/10.15420/aer.2019.8.3
-
Luca Sala, Massimiliano Gnecchi, Peter J Schwartz, et alArrhythmia & Electrophysiology Review 2019;8(2):105–10.DOI: https://doi.org/10.15420/aer.2019.1.1
-
Serge Sicouri, Charles AntzelevitchArrhythmia & Electrophysiology Review 2018;7(3):199–209.DOI: https://doi.org/10.15420/aer.2018.29.2
